Literature DB >> 12170058

Role of adenosine receptors in spinal G-protein activation after peripheral nerve injury.

Carsten Bantel1, Steven R Childers, James C Eisenach.   

Abstract

BACKGROUND: Spinally injected adenosine induces antinociception in animal models of neuropathic but not acute pain. The reasons for this discrepancy remain unclear. Adenosine receptors are coupled to G proteins, and increased efficiency of adenosine-induced G-protein activity in neuropathic pain could contribute to the antinociceptive effect of adenosine. In this study the authors used [(35)S]guanosine-5'-O-(3-thiotriphosphate) ([(35)S]GTP gamma S) autoradiography in rat spinal cord sections to test this possibility.
METHODS: The spinal cords of normal animals and those that underwent left L5 and L6 spinal nerve ligation (SNL) were removed and immediately frozen. Horizontal spinal cord sections were cut and mounted on chrom-alum gelatin-subbed slides. Sections were incubated with guanosine diphosphate, [(35)S]GTP gamma S, the adenosine A1 agonist R-N6-phenylisopropyladenosine, and various other drugs, apposed to films, and analyzed.
RESULTS: Baseline and R-N6-phenylisopropyladenosine-stimulated [(35)S]GTP gamma S binding was predominantly localized to the superficial dorsal horns of both normal and SNL animals. This binding was significantly increased in SNL compared with normal animals. In contrast, no difference in R-N6-phenylisopropyladenosine-stimulated [(35)S]GTP gamma S binding was observed between SNL and normal animals. Blockade of adenosine A1 receptors by 1,3-dipropyl-8-cyclopentylxanthine, or adenosine destruction by added adenosine deaminase, reduced the increased basal activity in SNL to baseline levels of normal dorsal horns, whereas atropine and naloxone had no effect.
CONCLUSION: This study shows an increased basal G-protein activity in lumbar spinal cords during conditions of SNL. The data suggest that increased adenosine release during conditions of SNL results in an increased basal activity of G proteins in the spinal cord during neuropathic pain.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12170058     DOI: 10.1097/00000542-200206000-00025

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  5 in total

1.  Statistical parametric mapping reveals regional alterations in cannabinoid CB1 receptor distribution and G-protein activation in the 3D reconstructed epileptic rat brain.

Authors:  Katherine W Sayers; Peter T Nguyen; Robert E Blair; Laura J Sim-Selley; Robert J DeLorenzo
Journal:  Epilepsia       Date:  2012-04-17       Impact factor: 5.864

Review 2.  Implication of the purinergic system in alcohol use disorders.

Authors:  Liana Asatryan; Hyung W Nam; Moonnoh R Lee; Mahesh M Thakkar; M Saeed Dar; Daryl L Davies; Doo-Sup Choi
Journal:  Alcohol Clin Exp Res       Date:  2011-01-11       Impact factor: 3.455

3.  Central or peripheral delivery of an adenosine A1 receptor agonist improves mechanical allodynia in a mouse model of painful diabetic neuropathy.

Authors:  N K Katz; J M Ryals; D E Wright
Journal:  Neuroscience       Date:  2014-11-08       Impact factor: 3.590

4.  Gallic acid modulates purine metabolism and oxidative stress induced by ethanol exposure in zebrafish brain.

Authors:  Samira Leila Baldin; Karolyne de Pieri Pickler; Ana Caroline Salvador de Farias; Henrique Teza Bernardo; Rahisa Scussel; Bárbara da Costa Pereira; Suzielen Damin Pacheco; Eduardo Ronconi Dondossola; Ricardo Andrez Machado-de-Ávila; Almir Gonçalves Wanderley; Eduardo Pacheco Rico
Journal:  Purinergic Signal       Date:  2022-06-10       Impact factor: 3.950

5.  Lack of efficacy of a partial adenosine A1 receptor agonist in neuropathic pain models in mice.

Authors:  Katharina Metzner; Tilman Gross; Annika Balzulat; Gesine Wack; Ruirui Lu; Achim Schmidtko
Journal:  Purinergic Signal       Date:  2021-07-27       Impact factor: 3.765

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.